DISEASE INDICATIONS: Pancreatic Cancer

MANUFACTURER: Baxalta Innovations GmbH

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Onivyde (irinotecan hydrochloride trihydrate) is an injectable medication used to treat metastatic adenocarcinoma of the pancreas. It works by inhibiting topoisomerase I, an enzyme necessary for DNA replication in cancer cells.